USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
The New Age of Regenerative Medicine
The New Age of Regenerative Medicine
Why Stem Cell Therapy?
RELEASE DATE
02-Sep-2015
02-Sep-2015
REGION
Global
Global
Research Code: 9AB9-00-3D-00-00
SKU: LS00078-GL-MR_16919
$1,500.00
In stock
SKU
LS00078-GL-MR_16919
Description
Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases such as cancer, heart disease, and neuro-muscular ailments among the ageing population. This research study provides an overview of the regenerative medicine industry and an insight on successful stem cell therapy treatments. It also analyses marketed products, stem cell manufacturing and funding, and the collaborative partnerships in the regenerative medicine industry.
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Key Findings
Key Questions This Study Will Answer
Regenerative Medicine Industry—Where We Stand Today
Regenerative Medicine Industry—Where We Stand Today (continued)
Regenerative Medicine Industry—Key Stakeholders
Definition—Regenerative Medicine
Regenerative Medicine—Market Segmentation
Why is Regenerative Medicine Important to the Future of Healthcare?
Market Size and Growth—Regenerative Medicine
Geographical Overview for Regenerative Medicine Companies
Total Regenerative Medicine Industry
Definitions—Cell Therapy and Stem Cell Therapy
Cell Therapy—Commercially Available Products by Therapy
Overview of Competing Products—By Development and Key Participants
Commercially Available Primary Cell Therapy and Allograft Products
Commercially Available Primary Cell Therapy and Allograft Products (continued)
Cellular Dynamics International (CDI), Madison, Wisconsin
Orthofix International, Lewisville, Texas
Capricor Therapeutics, Beverly Hills, California
Big Pharmaceuticals and Regenerative Medicine
Market Drivers and Restraints for Stem Cell Manufacturing
Stem Cell Consumer Information—The United States
Stem Cell Consumer Information—Global
Future Trends
Market Opportunities
Global Partnerships and Deals for Regenerative Medicine
Key Global Partnerships and Deals for Regenerative Medicine
Regenerative Medicine Market—Funding Scenario
Regenerative Medicine—Asia-Pacific Market Overview
Regenerative Medicine—Leading APAC Countries
Regenerative Medicine—Leading APAC Countries(continued)
Regenerative Medicine—Lifecycle for Leading APAC Countries
Regenerative Medicine—South Korea
Regenerative Medicine—China
Regenerative Medicine—Japan
Regenerative Medicine—Singapore
Regenerative Medicine—Key Market Access Barriers
Successful Stem Cell Therapy Company—MEDIPOST Co., Ltd.
Successful Stem Cell Therapy Company—Mesoblast Ltd.
The Last Word
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases such as cancer, heart disease, and neuro-muscular ailments among the ageing population. This research study provides an overview of the regenerative medicine industry and an insight on successful stem cell therapy treatments. It also analyses marketed products, stem cell manufacturing and funding, and the collaborative partnerships in the regenerative medicine industry.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Jane Andrews, Ph.D. |
| WIP Number | 9AB9-00-3D-00-00 |
| Is Prebook | No |